VolitionRx Limited Statistics
Share Statistics
VolitionRx Limited has 95.97M shares outstanding. The number of shares has increased by 16.94% in one year.
| Shares Outstanding | 95.97M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 4.2% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 70.76M |
| Failed to Deliver (FTD) Shares | 106.08K |
| FTD / Avg. Volume | 38.75% |
Short Selling Information
The latest short interest is 441.92K, so 0.46% of the outstanding shares have been sold short.
| Short Interest | 441.92K |
| Short % of Shares Out | 0.46% |
| Short % of Float | 0.62% |
| Short Ratio (days to cover) | 3.71 |
Valuation Ratios
The PE ratio is -1.45 and the forward PE ratio is -4.58.
| PE Ratio | -1.45 |
| Forward PE | -4.58 |
| PS Ratio | 65.88 |
| Forward PS | 1.9 |
| PB Ratio | -6.55 |
| P/FCF Ratio | -2.67 |
| PEG Ratio | n/a |
Enterprise Valuation
VolitionRx Limited has an Enterprise Value (EV) of 36.20M.
| EV / Earnings | -1.03 |
| EV / Sales | 46.7 |
| EV / EBITDA | -1.06 |
| EV / EBIT | -1.01 |
| EV / FCF | -1.89 |
Financial Position
The company has a current ratio of 0.69, with a Debt / Equity ratio of -0.62.
| Current Ratio | 0.69 |
| Quick Ratio | 0.69 |
| Debt / Equity | -0.62 |
| Total Debt / Capitalization | -162.67 |
| Cash Flow / Debt | -3.74 |
| Interest Coverage | -162.38 |
Financial Efficiency
Return on equity (ROE) is 4.53% and return on capital (ROIC) is 1260.79%.
| Return on Equity (ROE) | 4.53% |
| Return on Assets (ROA) | -1.26% |
| Return on Capital (ROIC) | 1260.79% |
| Revenue Per Employee | 7.68K |
| Profits Per Employee | -349.69K |
| Employee Count | 101 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -30.82% in the last 52 weeks. The beta is 1.1, so VolitionRx Limited's price volatility has been higher than the market average.
| Beta | 1.1 |
| 52-Week Price Change | -30.82% |
| 50-Day Moving Average | 0.65 |
| 200-Day Moving Average | 0.68 |
| Relative Strength Index (RSI) | 54.21 |
| Average Volume (20 Days) | 273.73K |
Income Statement
In the last 12 months, VolitionRx Limited had revenue of 775.30K and earned -35.32M in profits. Earnings per share was -0.5.
| Revenue | 775.30K |
| Gross Profit | 775.30K |
| Operating Income | -35.99M |
| Net Income | -35.32M |
| EBITDA | -34.04M |
| EBIT | -35.99M |
| Earnings Per Share (EPS) | -0.5 |
Balance Sheet
The company has 20.73M in cash and 5.86M in debt, giving a net cash position of 14.87M.
| Cash & Cash Equivalents | 20.73M |
| Total Debt | 5.86M |
| Net Cash | 14.87M |
| Retained Earnings | -202.58M |
| Total Assets | 12.68M |
| Working Capital | -23.48M |
Cash Flow
In the last 12 months, operating cash flow was -18.06M and capital expenditures -1.08M, giving a free cash flow of -19.15M.
| Operating Cash Flow | -18.06M |
| Capital Expenditures | -1.08M |
| Free Cash Flow | -19.15M |
| FCF Per Share | -0.27 |
Margins
Gross margin is 10.00K%, with operating and profit margins of -464.18K% and -455.55K%.
| Gross Margin | 10.00K% |
| Operating Margin | -464.18K% |
| Pretax Margin | -460.17K% |
| Profit Margin | -455.55K% |
| EBITDA Margin | -4.39K% |
| EBIT Margin | -4.64K% |
| FCF Margin | -2.47K% |
Dividends & Yields
VNRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -75.76% |
| FCF Yield | -30.14% |
Analyst Forecast
The average price target for VNRX is $5, which is 657.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $5 |
| Price Target Difference | 657.6% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Scores
| Altman Z-Score | -33.57 |
| Piotroski F-Score | 3 |